Novartis Manufacturing SA
980.0 FTENovartis Manufacturing reported revenue of €256.5m for the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026), with 980 full-time equivalents.
By total assets for 2025, Novartis Manufacturing ranks among the 10 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Novartis Manufacturing shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +19 % Equity +16 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 15 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Novartis Manufacturing's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 04 Aug 2023
- Year ended 31 Dec 2021filed on 27 Sep 2022
Novartis Manufacturing's financial analysis
- Solvency52.0%sector median: 47.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Novartis Manufacturing
Novartis Manufacturing's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0402.134.977
- VAT number
- BE0402134977
- Peppol
- Registered · 0208:0402134977 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Jan 1962
- Registered office
- 2870 Puurs-Sint-Amands
- Size
- Large · 980.0 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Novartis Manufacturing (SA) has been based in Puurs-Sint-Amands since 1962, active in: manufacture of medicaments. For 2025, it reports revenue of €256.5m, a net profit of €6.76m and equity of €148.4m. With 980.0 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 52.0%, above the median of its sector (47.2%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Novartis Manufacturing
Companies in the same business, of comparable size and area, outside its group.
- Ajinomoto Omnichem Manufacture of basic pharmaceutical products Wetteren · balance sheet €476.3m
- Roche Manufacture of pharmaceutical preparations Anderlecht · balance sheet €164.7m
- PHOENIX Pharma Belgium Manufacture of pharmaceutical preparations Woluwe-Saint-Lambert · balance sheet €235.4m
- PolyPeptide Manufacture of basic pharmaceutical products Braine-l'Alleud · balance sheet €331.7m
- Pfizer Manufacture of pharmaceutical preparations Ixelles · balance sheet €377.4m
- SERB Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €159.3m
- Novo Nordisk Production Belgium SA Manufacture of pharmaceutical preparations Brussels · balance sheet €153.5m
- Baxalta Belgium Manufacturing Manufacture of basic pharmaceutical products Lessines · balance sheet €713.1m
Frequently asked questions about Novartis Manufacturing
What is the revenue of Novartis Manufacturing?
According to the 2025 annual accounts filed with the NBB, the revenue of Novartis Manufacturing amounts to 256,546,233 €.
What is the VAT number of Novartis Manufacturing?
In Belgium, the VAT number is the company number prefixed with BE: BE0402134977 for Novartis Manufacturing, if the company is VAT-registered. Its company number (CBE) is 0402.134.977.
Where is the registered office of Novartis Manufacturing?
According to the CBE register, the registered office of Novartis Manufacturing is in 2870 Puurs-Sint-Amands.
What is the equity of Novartis Manufacturing?
At the close of the 2025 financial year, the equity of Novartis Manufacturing amounts to 148,417,893 €, a solvency of 52.0% of total assets.
How many people work at Novartis Manufacturing?
980.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Novartis Manufacturing?
The register lists 3 active mandates at Novartis Manufacturing. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Novartis Manufacturing within its sector?
By total assets for 2025, Novartis Manufacturing ranks among the 10 largest of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.
The full file of Novartis Manufacturing
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →